Julie Lim
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Synthetic Organic Chemistry Methods, Histone Deacetylase Inhibitors Research, HIV Research and Treatment, Insect-Plant Interactions and Control
Most-Cited Works
- → Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase(2003)95 cited
- → Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure–activity relationships of apicidin. Part 2(2001)69 cited
- → Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure–activity relationships of apicidin. Part 1(2001)63 cited
- → Discovery of the Development Candidate N-tert-Butyl Nodulisporamide: A Safe and Efficacious Once Monthly Oral Agent for the Control of Fleas and Ticks on Companion Animals(2009)29 cited
- → Chemical modification of nodulisporic acid A: preliminary structure–activity relationships(2000)25 cited
- → Monoclonal and Polyclonal Antibodies: Reagents for Studying HIV-1 Proteinase Variants(1991)2 cited
- → Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven Malignancies(2026)